List of Studies ( Metabolite:3-Aminoquinoline)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004153 | AN006894 | Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model | Feces | Rat | Shanghai Jiao Tong University | LC-MS | |
| ST003213 | AN005269 | The central role of creatine and polyamines in fetal growth restriction | Placenta | Human | Placenta disease | University of Udine | LC-MS |
| ST002787 | AN004534 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Feces | Human | Cancer | Wuhan University of Science and Technology | LC-MS |
| ST002505 | AN004126 | A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) | Cultured cells | Human | Cancer | University of Science and Technology of China | LC-MS |
| ST002405 | AN003919 | Stool global metabolite levels in peanut allergy (Part 2) | Feces | Human | Peanut allergy | Icahn School of Medicine at Mount Sinai | LC-MS |
| ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST002003 | AN003266 | A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 4) | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | Columbia University | LC-MS |
| ST001844 | AN002987 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part III) | Blood | Human | Fatty liver disease | University of California, Davis | GC-MS |
| ST001844 | AN002987 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part III) | Liver | Human | Fatty liver disease | University of California, Davis | GC-MS |
| ST001753 | AN002856 | Modifying Chromatography Conditions for Improved Unknown Feature Identification in Untargeted Metabolomics | Blood | Human | University of Michigan | LC-MS | |
| ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000047 | AN000081 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000076 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000077 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
